Company / Current Liabilities per Share
FENNEC PHARMACEUTICALS INC. Current Liabilities per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.38
FY2025
5-year range
$0.06 / $0.38
FY2021-FY2025
Trend
+49.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share has fluctuated over the past 10 years, ranging from $0.04 in FY2016 to $0.38 in FY2025.
Based on SEC 10-K filings.
0.38 in FY2025 with a 10-year CAGR of +24.0%.
Increased from $0.29 to $0.38 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +24.0%
Key checks
Key Insights
- In FY2025, current liabilities per share increased 49.3% year-over-year.
- Lowest current liabilities per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.38 | +49.3% |
| FY2024 | $0.26 | -10.7% |
| FY2023 | $0.29 | +350.4% |
| FY2021 | $0.06 | -44.3% |
| FY2019 | $0.11 | +28.4% |
| FY2018 | $0.09 | -26.2% |
| FY2017 | $0.12 | +227.9% |
| FY2016 | $0.04 | -17.4% |
| FY2015 | $0.04 | -75.4% |
| FY2014 | $0.18 | +42.0% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026